• If you aren’t losing weight while following a healthy plan, it might be because you’re not getting enough sleep, not drinking enough water, or not exercising enough.
• To get back on track with your weight loss goals, you should also make sure to cut back on alcohol, reduce your calories, and try to relieve stress.
• If you are still not losing weight, check in with your doctor, as it may be due to an underlying medical condition or certain medications you are taking.

Countless guides exist on how to lose weight, which makes it hard to figure out what approach is right for you. However, before you start trying to lose weight, it’s important to consider whether or not you should lose weight — and if so, how much is healthy.

Therefore, you should consult with your doctor before beginning any weight loss program, as they can help you decide

Adding exercise to a genetic treatment for myotonic dystrophy type 1 (DM1) was more effective at reversing fatigue than administering the treatment alone in a study using a mouse model of the disease. In fact, exercise alone provided some benefit whereas the genetic treatment alone did not. This study, carried out by researchers at the Massachusetts General Hospital (MGH) and collaborators, has implications for patients who experience fatigue due to genetics-related musculoskeletal diseases as well as other types of illness-induced fatigue. The study appears in Molecular Therapy – Nucleic Acids.

It’s encouraging that exercise makes a noticeable difference on its own and in combination with a genetic treatment specifically tailored for the disease.”

Thurman M. Wheeler, MD, Investigator, Department of Neurology at MGH and at Harvard Medical School

Wheeler was the senior author of the study.

DM1 is the most common muscular dystrophy in adults,

Montreal, Canada – ( NewMediaWire ) – November 27, 2020 – Vision Marine Technologies Inc. (Nasdaq: VMAR), the leading provider of electric technology in the design and manufacture of the first fully electric powertrain outboard motor (E-Motion) and electric power boats, today announced the closing of its initial public offering of 2,760,000 common shares at a price of US$10.00 per share, which includes 360,000 shares sold upon full exercise of the underwriter’s option to purchase additional common shares. The gross proceeds from the offering, including the exercise of the over-allotment option, were US$27,600,000, before deducting underwriting discounts, commissions and offering expenses. 

ThinkEquity, a division of Fordham Financial Management, Inc., acted as sole book-running manager for the offering.  

Vision intends to use the net proceeds from the offering for sales and marketing, build-up of inventory for order fulfillment, research and development, development of rental operations, and general working capital.

A registration

The MarketWatch News Department was not involved in the creation of this content.

NORWALK, Conn., Nov 24, 2020 (GLOBE NEWSWIRE via COMTEX) —
NORWALK, Conn., Nov. 24, 2020 (GLOBE NEWSWIRE) — Reed’s Inc. (Nasdaq: REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, today announced it has closed its previously announced underwritten public offering of 18,750,000 shares and the full exercise of the underwriters’ option to purchase an additional 2,812,500 shares. In total, the Company issued 21,562,500 of its common stock at a price of $0.56 per share for gross proceeds of approximately $12.1 million. Included within the total offering amount, members of Reed’s Board of Directors and senior management invested in the aggregate of approximately $625,000.

There’s an unlikely supplement and common supplement that scientists are now saying may help fend off COVID-19, and there’s a good chance you might have it in your medicine cabinet.

According to a Yahoo.com report, a recent study published by the Cleveland Clinic shows that melatonin — an inexpensive sleep hormone that is often produced in pill form for supplementation — shows some promise in helping fend off the disease.

According to the research, patients who took it were “significantly less likely to be diagnosed with COVID-19,” and that the findings were “particularly true for Black patients and those with diabetes.”

The report said the Cleveland Clinic’s study focused on finding “possible candidates for repurposing already-available drugs as treatments to protect people from COVID-19 or lessen the blow of an infection.” And, what they found, according to the report, was that folks “taking small daily doses” were 28-percent less

Remember when that science teacher John Cisna made headlines back in 2015 for losing more than 55 pounds in six months while eating only McDonald’s foods?

How did he do it? By limiting his caloric intake to 2,000 calories per day and exercising regularly. While a diet largely consisting of French fries and burgers and other foods high in fats may not be ideal for your heart or arteries, Cisna’s unique experiment proved that calorie regulation is the key to weight loss.

And in fact, a caloric deficit is the primary reason any specific type of diet can lead to weight loss. (Related: 100 Unhealthiest Foods on the Planet.)

One observational study of a group of Paleo Diet followers found that followers of the heart-healthy diet lost an average of five pounds over a three week period, but this weight loss came not only with a shift to eschewing beans,